1.北京中医药大学第三附属医院 北京 100029
2.石家庄市中医院
高辰,男,硕士,主治医师
# 李仝,男,博士,教授、主任医师,博士生导师,E-mail:litong_cool@163.com
纸质出版日期:2021-07-30,
收稿日期:2020-11-10,
移动端阅览
高辰, 宋凤丽, 康宁, 等. 温阳消水方外敷神阙穴治疗恶性腹腔积液脾肾阳虚证的临床研究[J]. 现代中医临床, 2021,28(4):12-17.
Chen Gao, Fengli Song, Ning Kang, et al. Clinical study of externally applied Wenyang Xiaoshui Formula on the Shenque acupoint for malignant ascites of the spleen-kidney yang-deficiency pattern[J]. Modern Chinese Clinical Medicine, 2021,28(4):12-17.
高辰, 宋凤丽, 康宁, 等. 温阳消水方外敷神阙穴治疗恶性腹腔积液脾肾阳虚证的临床研究[J]. 现代中医临床, 2021,28(4):12-17. DOI: 10.3969/j.issn.2095-6606.2021.04.003.
Chen Gao, Fengli Song, Ning Kang, et al. Clinical study of externally applied Wenyang Xiaoshui Formula on the Shenque acupoint for malignant ascites of the spleen-kidney yang-deficiency pattern[J]. Modern Chinese Clinical Medicine, 2021,28(4):12-17. DOI: 10.3969/j.issn.2095-6606.2021.04.003.
目的
2
观察温阳消水方外敷神阙穴治疗恶性腹腔积液脾肾阳虚证的临床疗效。
方法
2
将40例恶性腹腔积液患者随机分为治疗组20例、对照组20例,剔除脱落病例后,治疗组18例、对照组17例。对照组根据患者一般情况进行基础治疗,如营养支持、补充白蛋白、利尿等常规治疗,治疗组在对照组治疗的基础上联合温阳消水方外敷神阙穴治疗。观察腹腔积液最大液深值、平脐腹围值、24 h尿量、临床症状评分、卡氏(KPS)评分、腹腔积液消退疗效,并进行安全性评价。
结果
2
腹腔积液最大液深值、平脐腹围值治疗组治疗后较本组治疗前均降低(
P
<
0.05),对照组治疗后与本组治疗前比较,差异均无统计学意义(
P
>
0.05),治疗组治疗后较对照组降低明显(
P
<
0.05)。24 h尿量治疗组治疗后较本组治疗前增加(
P
<
0.05),对照组治疗后与本组治疗前比较,差异无统计学意义(
P
>
0.05),治疗组治疗后较对照组增加明显(
P
<
0.05)。临床症状评分2组治疗后较本组治疗前均降低(
P
<
0.05),治疗组较对照组降低明显(
P
<
0.05)。KPS评分治疗组治疗后较本组治疗前升高(
P
<
0.05),对照组治疗后与本组治疗前比较,差异无统计学意义(
P
>
0.05),治疗组治疗后较对照组升高明显(
P
<
0.05)。治疗组腹腔积液消退疗效优于对照组(
P
<
0.05)。观察2组血常规、肝功能、肾功能检查结果,未见明显不良反应。
结论
2
温阳消水方外敷神阙穴治疗恶性腹腔积液具有较好的疗效。
Objective
2
To observe the clinical efficacy of externally applied Wenyang Xiaoshui Formula on the Shenque acupoint in patients with malignant ascites of the spleen-kidney yang-deficiency pattern.
Methods
2
Forty patients with malignant ascites were randomly assigned to the treatment group (
n
=20) and control group (
n
=20). With the withdrawal or drop-out excluded
there were 18 cases left in treatment group and 17 in control group. The control group received basic treatment based on the general conditions of the patients
for instance
nutritional support
albumin supplementation
diuretic and other conventional treatments. Apart from the basis of the treatment that control group received
the treatment group received additional externally applied Wenyang Xiaoshui Formula on the Shenque acupoint. The maximum fluid depth in the abdominal cavity
umbilical horizontal abdominal circumference
urine output in 24 hours
clinical symptom score
Karnofsky (KPS) score
efficacy of ascites regression were observed
and its safety was evaluated.
Results
2
The maximum fluid depth in the abdominal cavity
umbilical horizontal abdominal circumference were significantly decreased after treatment in the treatment group(
P
<
0.05)
but there were no significant differences in the control group after treatment(
P
>
0.05). There was significant difference between the two groups (
P
<
0.05). The urine output in 24 hours were increased after treatment in the treatment group (
P
<
0.05)
but there was no significant difference in the control group after treatment(
P
>
0.05). The urine output in 24 hours was more significantly increased in the treatment group than in the control group after treatment (
P
<
0.05). Clinical symptom scores were significantly decreased after treatment in both groups(
P
<
0.05)
more in the treatment group than in the control group after treatment(
P
<
0.05). KPS scores were significantly increased in the treatment group after treatment(
P
<
0.05)
but not in the control group after treatment(
P
>
0.05). KPS scores were more significantly increased in treatment group than in the control group after treatment(
P
<
0.05). The efficacy of ascites regression was significantly better in the treatment group than in the control group(
P
<
0.05). The blood routine
liver function
and renal function tests in the two groups were observed
with no significant adverse reactions.
Conclusions
2
The externally applied Wenyang Xiaoshui Formula on the Shenque acupoint is effective in relieving malignant ascites.
温阳消水方外敷神阙穴恶性腹腔积液中医外治临床研究
Wenyang Xiaoshui Formulaexternal applicationShenque acupointmalignant ascitesexternal treatment of TCMclinical research
ENCK R E.More on the management of ascites[J].American Journal of Hospice and Palliative Medicine,2012,29(5):333-334.
AMMOURI L, PROMMER E.Palliative treatment of malignant ascites: profile of catumaxomab[J].Biologics: Targets and Therapy,2010,4:103-110.
李晓芳,王海雄,裴毅.重组改构人肿瘤坏死因子与顺铂治疗恶性胸/腹腔积液的临床对比观察[J].临床医药实践,2015,24(6):406-408.
王蔚文,文格波,龙开超,等.临床疾病诊断与疗效判断标准[M].北京:科学技术文献出版社,2010:1347-1428.
国家中医药管理局医政司.中医病证诊断疗效标准[M].北京:中国中医药出版社,2013:17-18.
石远凯,孙燕.临床肿瘤内科学手册[M].5版.北京:人民卫生出版社,2008.
EISENHAUER E, THERASSE P, BOGAERTS J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45(2):228-247.
许叔微.普济本事方[M].刘景超,李具双,校注.北京:中国中医药出版社,2007:54.
宋凤丽,康宁,王文雯,等.中医药治疗恶性腹水证候及用药规律分析[J].中医学报,2018,33(12):2298-2303.
张仲景.金匮要略[M].何任,何若苹,整理.北京:人民卫生出版社,2005:54.
吕景山.施今墨对药[M].3版.北京:人民军医出版社,2006:338.
吴尚先.理瀹骈文[M].2版.张年顺,张向群,萧龙生,编校.北京:中国中医药出版社,2007:24.
宋凤丽,朱旭,高辰,等.温阳消水方治疗癌性腹水的临床观察及机制研究[J].中华中医药杂志,2016,31(4):1513-1516.
徐大椿.医学源流论[M].万芳,整理.北京:人民卫生出版社,2007:50.
杜祖光,张涛,李海英,等.中药逐水复方神阙穴外敷对恶性腹腔积液患者免疫功能的影响[J].山西医药杂志,2012,41(2):113-114.
ZHANG Y, LOU J W, KANG A, et al.Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions[J/OL].Journal of Ethnopharmacology,2020[2020-11-10].https://www.sciencedirect.com/science/article/abs/pii/S0378874119336335?via%3Dihubhttps://www.sciencedirect.com/science/article/abs/pii/S0378874119336335?via%3Dihub.DOI:10.1016/j.jep.2019.112423http://doi.org/10.1016/j.jep.2019.112423.
0
浏览量
9
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构